Yikon Genomics – Integrated NGS and IVD Solutions for Reproductive Health
Yikon Genomics, founded in 2012 and headquartered in Shanghai, is a leading biotech company providing NGS-based and IVD-certified solutions in reproductive health and oncology. Powered by its patented MALBAC® whole-genome amplification technology, Yikon offers a comprehensive portfolio including PGT-A (MALBAC‑PGS™), PGT-M (MALBAC‑PGD™), KaryoSeq® (for PGT-A/M/SR), and noninvasive PGT-A (NICS‑A™). Their Endometrial Receptivity Test (ERT), integrated with ChromGo™ software, further supports personalized embryo transfer decisions.
With GMP-certified facilities, CLIA/CAP-accredited laboratories, and global reach, Yikon Genomics enables high-throughput, accurate, and safe genetic testing workflows. The company is committed to advancing precision medicine through innovation in reproductive genomics, oncology, and IVD molecular diagnostics.